Objective To investigate the predictive value of serum epithelial cell homeostasis-signal transduction markers—cytokeratin 19 fragment(CYFRA21-1)and β-arrestin-2—for the development of clinically significant portal hyper-tension(CSPH)in patients with liver cirrhosis.Methods A total of 287 patients with liver cirrhosis admitted to the Depart-ment of Gastroenterology,Sinopharm Tongmei General Hospital from April 2021 to October 2025 were enrolled as the cirrho-sis group,and 287 healthy individuals undergoing physical examinations at the same hospital during the same period were se-lected as the healthy control group.The cirrhosis group was further divided into a CSPH subgroup(80 cases)and a non-CSPH subgroup(207 cases)based on hepatic venous pressure gradient(HVPG)measurements.Serum levels of CYFRA21-1 and β-arrestin-2 were measured using enzyme-linked immunosorbent assay.Pearson correlation analysis was performed to assess the correlation between CYFRA21-1,β-arrestin-2,and HVPG values.Multivariate logistic regression analysis was used to identify risk factors for CSPH in patients with liver cirrhosis.Receiver operating characteristic(ROC)curves were applied to evaluate the value of CYFRA21-1 and β-arrestin-2 in predicting CSPH in cirrhotic patients.Results Serum levels of CYFRA21-1 and β-arrestin-2 in the cirrhosis group were significantly higher than those in the healthy control group(t=23.097,26.485;both P<0.001).Serum levels of CYFRA21-1 and β-arrestin-2 in the CSPH subgroup were significantly higher than those in the non-CSPH subgroup(t=13.927,10.981;both P<0.001).Serum CYFRA21-1 and β-arrestin-2 levels were positively correlated with HVPG values(r=0.615,0.553;both P<0.001).The proportions of esophagogastric varices,Child-Pugh grade C,liver stiffness measurement,FIB-4 index,and INR in the CSPH subgroup were significantly higher than those in the non-CSPH subgroup,while albumin and platelet counts were significantly lower(χ2/t=22.182,26.093,22.177,14.979,12.222,11.280,18.463;all P<0.001).High CYFRA21-1,high β-arrestin-2,and high liver stiffness measurement were inde-pendent risk factors for CSPH in patients with cirrhosis,while high platelet count was an independent protective factor[OR(95%CI)=1.844(1.286-2.645),2.450(1.498-4.008),1.203(1.087-1.332),0.972(0.955-0.990)].The AUCs of serum CYFRA21-1,β-arrestin-2,and their combination for diagnosing CSPH in patients with cirrhosis were 0.794,0.799,and 0.884,respectively.The combined diagnosis showed significantly higher AUC than either single marker(Z=3.738,2.713;P<0.001,0.006).Conclusion Serum levels of CYFRA21-1 and β-arrestin-2 are significantly elevated in patients with liver cirrhosis and are closely associated with HVPG and the development of CSPH.Combined detection of these two markers demonstrates high predictive value for CSPH in cirrhotic patients.